TrianglePUBLICATIONS · 21815133
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2011 Aug 15
- First author
- McGonigle KF
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- McGonigle KF
- type
- Author
- name
- Muntz HG
- type
- Author
- name
- Vuky J
- type
- Author
- name
- Paley PJ
- type
- Author
- name
- Veljovich DS
- type
- Author
- name
- Greer BE
- type
- Author
- name
- Goff BA
- type
- Author
- name
- Gray HJ
- type
- Author
- name
- Malpass TW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- McGonigle KF
- type
- Author
- name
- Muntz HG
- type
- Author
- name
- Vuky J
- type
- Author
- name
- Paley PJ
- type
- Author
- name
- Veljovich DS
- type
- Author
- name
- Greer BE
- type
- Author
- name
- Goff BA
- type
- Author
- name
- Gray HJ
- type
- Author
- name
- Malpass TW
- type
- Author
- bibliography ids
- nci-bib-edaab218f522fb16b0771a70
- book metadata
- content sha256
- 36433833b5a8194dbcce9c6cd9a4e3821e40be0626ae8aaeaf2b12bbae854e1b
- document type
- citation
- dois
- 10.1002/cncr.25967
- electronic publication date
- display
- 2011 Feb 24
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21815133
- immutable id
- pubmed:21815133@36433833b5a8194dbcce9c6cd9a4e3821e40be0626ae8aaeaf2b12bbae854e1b
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 16
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 3731-40
- volume
- 117
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21815133
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- 822bf11a688e88c1fde81a1aabd3bb018ab8bc111109b46514af3e87c27a4cc7
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2011 Aug 15
- precision
- day
- year
- 2011
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.
Preserved source evidence · Not medical advice